Related Experiment Video
Updated: Oct 4, 2025
09:29
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.3K
Understanding and co-managing medication treatment options for opioid use disorder
Abigail Kay1, Rachel Shmuts2, Melanie Beck3
1Department of Psychiatry and Human Behavior-Division of Substance Abuse, The Sidney Kimmel Medical College at Thomas Jefferson University, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Internal and Emergency Medicine
|February 9, 2022
Summary
Opioid use disorder (OUD) is common in primary care, yet training is lacking. This review covers three FDA-approved medications for OUD, aiding internists in patient care and recovery.
Area of Science:
- Internal Medicine
- Addiction Medicine
- Pharmacology
Background:
- Opioid use disorder (OUD) affects a significant portion of patients in primary care settings.
- There is a notable deficiency in medical education regarding the management of OUD.
- Internal medicine physicians require foundational knowledge of OUD physiology and treatment.
Purpose of the Study:
- To equip internists with essential knowledge for managing OUD.
- To enhance understanding of available treatment options for OUD.
- To improve patient outcomes and recovery rates for individuals with OUD.
Main Methods:
- Clinical review of FDA-approved medications for OUD.
- Comparison and contrast of medication-assisted treatments (MAT).
- Presentation of the three primary MATs: methadone, naltrexone, and buprenorphine.
Main Results:
- Identified three FDA-approved medications for OUD treatment.
- Provided a comparative analysis of these medications.
- Reviewed the clinical application of methadone, naltrexone, and buprenorphine.
Conclusions:
- Increased internist knowledge of OUD treatments can improve patient trust and outcomes.
- Effective management of OUD by internists can facilitate referrals and prevent medical complications.
- Understanding MAT is crucial for comprehensive OUD care.
Related Concept Videos
01:25Analgesia and Pain Management
891
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
891
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
429
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
429
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
481
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
481
01:28Drug Therapy
113
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
113
01:15Drug Abuse and Addiction: Pharmacological Phenomena
779
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
779
01:22Opioid Receptors: Overview
2.2K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.2K